Theriva Biologics Special Meeting Fails Due to Lack of Quorum

Theriva Biologics, Inc. announced that its Special Meeting of Stockholders, called for June 5, 2026, could not convene due to a lack of quorum. The meeting's primary purpose was to seek stockholder approval for the issuance of up to 16,184,560 shares of common stock upon the exercise of certain warrants, as stipulated by an Inducement Agreement from October 16, 2025. As a result, the company is now obligated to call additional stockholder meetings every 60 days until the necessary approval is secured or the warrants are no longer outstanding, unless waived by the investors.